Oppenheimer & CO Inc Ark Genomic Revolution ETF (De Transaction History
Oppenheimer & CO Inc
- $6.43 Billion
- Q1 2025
A detailed history of Oppenheimer & CO Inc transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Oppenheimer & CO Inc holds 18,663 shares of ARKG stock, worth $390,429. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,663Holding current value
$390,429% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$71.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$68.8 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$53.6 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$49.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$25.2 Million0.0% of portfolio